08/05/2026
Advancing Veterinary Dentistry with In-Clinic Precision: GLINX Collaborative Research at EVDF 2026 🦷🔬
We are thrilled to share our collaborative study presented at the European Veterinary Dental Forum (EVDF) 2026 in Porto, Portugal.
Poster Title:
The Importance of On-Site PCR Diagnostics in Managing Feline Oral Inflammatory Diseases🐱
Collaborators:
Ewa Chronowska, DVM, Resident EVDC, and Jerzy Gawor, DVM, PhD, DAVDC, DEVDC
Diagnostic Technology Partner:
Shanghai GlinX Biotechnology Co., Ltd. (GlinX)
Panel: InCycleFelineRespiratory5-in-1Panel
Feline Herpesirus type 1(FHV-I), Feline Calicivirus (FCV),Mycoplasma felis(M.felis), Chlamydophila felis(C.felis), and Bordetella bronchiseptica (B.b))
Key Research Insight:
Our study revealed that 80% of cats with oral inflammatory conditions tested positive for at least one respiratory pathogen, showcasing the role of infectious agents in feline oral diseases like stomatitis and refractory periodontitis. 🦠
Technology Advantage:
The InCycle PCR System provided same-day diagnostics, enabling real-time identification of pathogens and correlation with disease severity. ⏱️
Why It Matters:
In-clinic PCR speeds up diagnosis, enhances treatment precision, and reduces patient discomfort. We thank Dr. Chronowska and Dr. Gawor for their collaboration. At GlinX, we’re focused on making advanced diagnostics accessible and routine in veterinary practice for better patient outcomes. 🌍